about
Anticholinesterase treatment for myasthenia gravisSpecific immunotherapy of experimental myasthenia gravis by a novel mechanism.Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.Nationwide population-based epidemiological study of myasthenia gravis in taiwanAntigen-specific immunotherapeutic vaccine for experimental autoimmune myasthenia gravisImmune mediated diseases and immune modulation in the neurocritical care unitStandardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designsGender and Ethnicity Based Differences in Clinical and Laboratory Features of Myasthenia Gravis.Prevalence of immune disease in patients with wounds presenting to a tertiary wound healing centre.Prospects for a T-cell receptor vaccination against myasthenia gravis.Mycophenolate mofetil treatment of myasthenia gravis.Correlation of single-breath count test and neck flexor muscle strength with spirometry in myasthenia gravisThe Epidemiology of Myasthenia Gravis in Korea.Clinical profile and outcome of myasthenic crisis in a tertiary care hospital: A prospective studyTherapeutic Plasma Exchange in Neurologic Diseases: An Experience with 91 Patients in Seven Years.Cost analysis of myasthenia gravis from a large U.S. insurance database.Treatments to restore respiratory function after spinal cord injury and their implications for regeneration, plasticity and adaptation.The emerging role of tacrolimus in myasthenia gravis.Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society.Rapamycin alleviates inflammation and muscle weakness, while altering the Treg/Th17 balance in a rat model of myasthenia gravis.Variability in intravenous immunoglobulin G regimens for autoimmune neuromuscular disorders.Epidemiology and geographical variation of myasthenia gravis in the province of Pavia, Italy.
P2860
Q24243468-BE6DE7CD-EF87-4152-86F2-523028D65484Q33831279-ED77458C-D020-4264-9D21-5160795D73B9Q34043022-3FB9059A-EA26-47C4-A761-F9EB3950140FQ34057165-8AC93E82-4D83-4AB3-8B1A-3C30F735494DQ34755933-99B5372A-73DD-4EB3-AFFF-5E006CB7879BQ35729575-A54575DD-FD66-4433-B277-D9F98EC53724Q35738911-D9CFDF32-C27B-40AE-867A-8BED968102E3Q35794114-73C19061-9F17-4971-AB95-8819508B9B58Q36030909-4CCAA81B-C37B-4A5C-8313-BEDBFECF3E4BQ36238694-265FBAC1-F78A-40C6-9076-A33B580E70F5Q36364969-AA9CAE0C-6F58-4FF4-B717-659D4DEFED6CQ36470499-FA206C13-0E52-46BC-B180-1CEFE6826365Q36541587-27BD1CC4-B503-45D6-9B9C-D98310F4DA41Q37046686-92D36C6E-9BF2-4D4C-9600-073621AE9DF0Q37725863-F1E64F36-E9C0-4350-A1A4-F3AFA5261841Q37958826-527EDFB9-5F74-4F03-85BE-D51B800DE5F6Q37971436-6835D66E-A8FD-43F4-ABF3-0C0390798C8EQ38448460-1F629384-742F-4CAB-B0ED-78925EE34CAAQ42287591-6431562C-A45B-43AF-9E51-5D28C9E00818Q42334836-5217DD29-401E-4BD3-87A8-050A93D4BDE4Q45640650-E8CF5D15-83C9-4B5A-AAF0-9CFAC06D9661Q50960713-20A13C16-2478-4E7F-982D-0A8B79CFB3C3
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The epidemiology of myasthenia gravis.
@ast
The epidemiology of myasthenia gravis.
@en
type
label
The epidemiology of myasthenia gravis.
@ast
The epidemiology of myasthenia gravis.
@en
prefLabel
The epidemiology of myasthenia gravis.
@ast
The epidemiology of myasthenia gravis.
@en
P356
P1476
The epidemiology of myasthenia gravis.
@en
P2093
Lawrence H Phillips
P356
10.1055/S-2004-829593
P577
2004-03-01T00:00:00Z